Charles River Laboratories (CRL)

EBITDA Margin

5.51%

TTM · Period ending:

CRL logo

CRL EBITDA Margin

Latest reported5.51%
CRL TTM EBITDA Margin (27.38% → 5.51%)
High-resolution chart · PNG

CRL ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Charles River Laboratories EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
25.8051%
25.6775%
27.3761%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.